Apollomics (APLMW) Competitors $0.0096 +0.00 (+23.08%) As of 04/17/2025 12:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. Apollomics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Cingulate Apollomics (NASDAQ:APLMW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, community ranking, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment. Does the MarketBeat Community prefer APLMW or ATNFW? Apollomics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformApollomicsN/AN/A180 Life SciencesN/AN/A Is APLMW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor APLMW or ATNFW? In the previous week, Apollomics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Apollomics and 0 mentions for 180 Life Sciences. Apollomics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that Apollomics is being referred to more favorably in the media. Company Overall Sentiment Apollomics Positive 180 Life Sciences Neutral Which has preferable earnings and valuation, APLMW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomicsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryApollomics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$122.22M$5.32B$7.35BDividend YieldN/A3.82%5.47%4.34%P/E RatioN/A3.0521.9417.82Price / SalesN/A4,230.36380.9597.73Price / CashN/A13.2238.3134.64Price / BookN/A34.746.453.98Net IncomeN/A-$93.04M$3.22B$247.81M7 Day PerformanceN/A2.19%5.85%3.19%1 Month PerformanceN/A-5.51%-9.58%-7.70%1 Year PerformanceN/A85.44%11.85%1.49% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.01+23.1%N/A-61.6%$0.00N/A0.0059Short Interest ↓Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-2.5%N/A-12.2%$0.00N/A0.007SXTPW60 Degrees PharmaceuticalsN/A$0.06+82.3%N/A-50.2%$0.00$607,574.000.002Positive NewsHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.21+3.2%N/AN/A$0.00N/A0.0080Positive NewsWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.08+1.8%N/A-93.1%$0.00N/A0.008Gap DownCDIOWCardio DiagnosticsN/A$0.03+1.7%N/A-70.2%$0.00$34,890.000.007Short Interest ↑Gap UpCTCXWCarmellN/A$0.03+6.8%N/A-66.6%$0.00$32,839.000.0014Gap UpCELUWCelularityN/A$0.04+8.7%N/A+1.0%$0.00$48.20M0.00220Gap DownCEROWCERo TherapeuticsN/A$0.01-6.1%N/A-82.1%$0.00N/A0.008Positive NewsCINGWCingulateN/A$0.04-1.4%N/A+198.7%$0.00N/A0.0020Positive NewsGap Up Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLMW) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APLMW Stock Free APLMW Stock Alerts